These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 22281738)

  • 21. Dehydroalanine-based diubiquitin activity probes.
    Haj-Yahya N; Hemantha HP; Meledin R; Bondalapati S; Seenaiah M; Brik A
    Org Lett; 2014 Jan; 16(2):540-3. PubMed ID: 24364494
    [TBL] [Abstract][Full Text] [Related]  

  • 22. NF-kappaB activation: Nondegradative ubiquitination implicates NEMO.
    Israël A
    Trends Immunol; 2006 Sep; 27(9):395-7. PubMed ID: 16857427
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Structural determinants for selective recognition of a Lys48-linked polyubiquitin chain by a UBA domain.
    Varadan R; Assfalg M; Raasi S; Pickart C; Fushman D
    Mol Cell; 2005 Jun; 18(6):687-98. PubMed ID: 15949443
    [TBL] [Abstract][Full Text] [Related]  

  • 24. DARPin-assisted crystallography of the CC2-LZ domain of NEMO reveals a coupling between dimerization and ubiquitin binding.
    Grubisha O; Kaminska M; Duquerroy S; Fontan E; Cordier F; Haouz A; Raynal B; Chiaravalli J; Delepierre M; Israël A; Véron M; Agou F
    J Mol Biol; 2010 Jan; 395(1):89-104. PubMed ID: 19854204
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthesis and analysis of linear ubiquitin chains.
    Iwai K
    Methods Mol Biol; 2012; 832():229-38. PubMed ID: 22350889
    [TBL] [Abstract][Full Text] [Related]  

  • 26. New conformations of linear polyubiquitin chains from crystallographic and solution-scattering studies expand the conformational space of polyubiquitin.
    Thach TT; Shin D; Han S; Lee S
    Acta Crystallogr D Struct Biol; 2016 Apr; 72(Pt 4):524-35. PubMed ID: 27050132
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lysine 63 polyubiquitination in immunotherapy and in cancer-promoting inflammation.
    Martinez-Forero I; Rouzaut A; Palazon A; Dubrot J; Melero I
    Clin Cancer Res; 2009 Nov; 15(22):6751-7. PubMed ID: 19887490
    [TBL] [Abstract][Full Text] [Related]  

  • 28. NF-kappaB activation by combinations of NEMO SUMOylation and ATM activation stresses in the absence of DNA damage.
    Wuerzberger-Davis SM; Nakamura Y; Seufzer BJ; Miyamoto S
    Oncogene; 2007 Feb; 26(5):641-51. PubMed ID: 16862178
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Crystal structure of p50/p65 heterodimer of transcription factor NF-kappaB bound to DNA.
    Chen FE; Huang DB; Chen YQ; Ghosh G
    Nature; 1998 Jan; 391(6665):410-3. PubMed ID: 9450761
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Engineering and structural characterization of a linear polyubiquitin-specific antibody.
    Matsumoto ML; Dong KC; Yu C; Phu L; Gao X; Hannoush RN; Hymowitz SG; Kirkpatrick DS; Dixit VM; Kelley RF
    J Mol Biol; 2012 May; 418(3-4):134-44. PubMed ID: 22227388
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ubiquitin binding modulates IAP antagonist-stimulated proteasomal degradation of c-IAP1 and c-IAP2(1).
    Blankenship JW; Varfolomeev E; Goncharov T; Fedorova AV; Kirkpatrick DS; Izrael-Tomasevic A; Phu L; Arnott D; Aghajan M; Zobel K; Bazan JF; Fairbrother WJ; Deshayes K; Vucic D
    Biochem J; 2009 Jan; 417(1):149-60. PubMed ID: 18939944
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Engineered diubiquitin synthesis reveals Lys29-isopeptide specificity of an OTU deubiquitinase.
    Virdee S; Ye Y; Nguyen DP; Komander D; Chin JW
    Nat Chem Biol; 2010 Oct; 6(10):750-7. PubMed ID: 20802491
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A novel site for ubiquitination: the N-terminal residue, and not internal lysines of MyoD, is essential for conjugation and degradation of the protein.
    Breitschopf K; Bengal E; Ziv T; Admon A; Ciechanover A
    EMBO J; 1998 Oct; 17(20):5964-73. PubMed ID: 9774340
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Innate link between NF-kappaB activity and ubiquitin-like modifiers.
    Lang V; Rodríguez MS
    Biochem Soc Trans; 2008 Oct; 36(Pt 5):853-7. PubMed ID: 18793150
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular basis of Lys11-polyubiquitin specificity in the deubiquitinase Cezanne.
    Mevissen TET; Kulathu Y; Mulder MPC; Geurink PP; Maslen SL; Gersch M; Elliott PR; Burke JE; van Tol BDM; Akutsu M; Oualid FE; Kawasaki M; Freund SMV; Ovaa H; Komander D
    Nature; 2016 Oct; 538(7625):402-405. PubMed ID: 27732584
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular discrimination of structurally equivalent Lys 63-linked and linear polyubiquitin chains.
    Komander D; Reyes-Turcu F; Licchesi JD; Odenwaelder P; Wilkinson KD; Barford D
    EMBO Rep; 2009 May; 10(5):466-73. PubMed ID: 19373254
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Quasi-Racemic X-ray Structures of K27-Linked Ubiquitin Chains Prepared by Total Chemical Synthesis.
    Pan M; Gao S; Zheng Y; Tan X; Lan H; Tan X; Sun D; Lu L; Wang T; Zheng Q; Huang Y; Wang J; Liu L
    J Am Chem Soc; 2016 Jun; 138(23):7429-35. PubMed ID: 27268299
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Protein-protein interactions involving IKKgamma (NEMO) that promote the activation of NF-kappaB.
    Shifera AS
    J Cell Physiol; 2010 Jun; 223(3):558-61. PubMed ID: 20301198
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An Extended Conformation for K48 Ubiquitin Chains Revealed by the hRpn2:Rpn13:K48-Diubiquitin Structure.
    Lu X; Ebelle DL; Matsuo H; Walters KJ
    Structure; 2020 May; 28(5):495-506.e3. PubMed ID: 32160516
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Structure determination of the small ubiquitin-related modifier SUMO-1.
    Bayer P; Arndt A; Metzger S; Mahajan R; Melchior F; Jaenicke R; Becker J
    J Mol Biol; 1998 Jul; 280(2):275-86. PubMed ID: 9654451
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.